Autoimmune-Mediated Intestinal Inflammation-Impact and Regulation of Antigen-Specific CD8+ T Cells

Gastroenterology

Volumn 131, Issue 2, 2006, Pages 510-524

  Westendorf, Astrid Maria ^a   Fleissner, Diana ^a   Deppenmeier, Stefanie ^b   Gruber, Achim Dieter ^b   Bruder, Dunja ^a   Hansen, Wiebke ^a   Liblau, Roland ^c   Buer, Jan ^a,d  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CHU PURPAN   (France)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; ENTERITIS; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INTESTINE MUCOSA; LYMPHOID TISSUE; MALE; MATING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY; TRANSGENIC MOUSE; WASTING SYNDROME;

EID: 33746572247     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.05.015     Document Type: Article

References (51)

1. Wirtz S., and Neurath M.F. Animal models of intestinal inflammation. new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis 15 (2000) 144-160
2. Blumberg R.S., Saubermann L.J., and Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11 (1999) 648-656
3. Bregenholt S., Brimnes J., Nissen M.H., and Claesson M.H. In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts. Clin Exp Immunol 118 (1999) 228-234
4. high subset of CD4+ T cells. Am J Pathol 148 (1996) 1503-1515
5. low CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179 (1994) 589-600
6. hi CD4+ T cells. Immunity 1 (1994) 553-562
7. Westendorf A.M., Templin M., Geffers R., Deppenmeier S., Gruber A.D., Probst-Kepper M., Hansen W., Liblau R.S., Gunzer F., Bruder D., and Buer J. CD4+ T cell mediated intestinal immunity. chronic inflammation versus immune regulation. Gut 54 (2005) 60-69
8. Steinhoff U., Brinkmann V., Klemm U., Aichele P., Seiler P., Brandt U., Bland P.W., Prinz I., Zugel U., and Kaufmann S.H. Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells. Immunity 11 (1999) 349-358
9. Liu Z., and Lefrancois L. Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response. J Immunol 173 (2004) 4324-4330
10. Vezys V., Olson S., and Lefrancois L. Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity 12 (2000) 505-514
11. Vezys V., and Lefrancois L. Cutting edge. inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol 169 (2002) 6677-6680
12. Morgan D.J., Liblau R., Scott B., Fleck S., McDevitt H.O., Sarvetnick N., Lo D., and Sherman L.A. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 157 (1996) 978-983
13. Lanoue A., Bona C., von Boehmer H., and Sarukhan A. Conditions that induce tolerance in mature CD4+ T cells. J Exp Med 185 (1997) 405-414
14. Kirberg J., Baron A., Jakob S., Rolink A., Karjalainen K., and von Boehmer H. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med 180 (1994) 25-34
15. Guy-Grand D., Griscelli C., and Vassalli P. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med 148 (1978) 1661-1677
16. Zhang X., Izikson L., Liu L., and Weiner H.L. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol 167 (2001) 4245-4253
17. Manavalan J.S., Kim-Schulze S., Scotto L., Naiyer A.J., Vlad G., Colombo P.C., Marboe C., Mancini D., Cortesini R., and Suciu-Foca N. Alloantigen specific CD8+. Int Immunol 16 (2004) 1055-1068
18. Morgan M.E., van Bilsen J.H., Bakker A.M., Heemskerk B., Schilham M.W., Hartgers F.C., Elferink B.G., van der Z.L., de Vries R.R., Huizinga T.W., Ottenhoff T.H., and Toes R.E. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 66 (2005) 13-20
19. Xystrakis E., Cavailles P., Dejean A.S., Cautain B., Colacios C., Lagrange D., van de Gaar M.J., Bernard I., Gonzalez-Dunia D., Damoiseaux J., Fournie G.J., and Saoudi A. Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat. J Immunol 173 (2004) 3140-3147
20. Xystrakis E., Dejean A.S., Bernard I., Druet P., Liblau R., Gonzalez-Dunia D., and Saoudi A. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104 (2004) 3294-3301
21. Singh B., Read S., Asseman C., Malmstrom V., Mottet C., Stephens L.A., Stepankova R., Tlaskalova H., and Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev 182 (2001) 190-200
22. Mottet C., Uhlig H.H., and Powrie F. Cutting edge. cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170 (2003) 3939-3943
23. Apostolou I., and von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199 (2004) 1401-1408
24. Buer J., Lanoue A., Franzke A., Garcia C., von Boehmer H., and Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med 187 (1998) 177-183
25. Jooss K., Gjata B., Danos O., von Boehmer H., and Sarukhan A. Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci U S A 98 (2001) 8738-8743
26. Lechner O., Lauber J., Franzke A., Sarukhan A., von Boehmer H., and Buer J. Fingerprints of anergic T cells. Curr Biol 11 (2001) 587-595
27. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
28. Kamradt T., and Mitchison N.A. Tolerance and autoimmunity. N Engl J Med 344 (2001) 655-664
29. von Boehmer H. Selection of the T-cell repertoire. receptor-controlled checkpoints in T-cell development. Adv Immunol 84 (2004) 201-238
30. Tanchot C., Vasseur F., Pontoux C., Garcia C., and Sarukhan A. Immune regulation by self-reactive T cells is antigen specific. J Immunol 172 (2004) 4285-4291
31. Thorstenson K.M., and Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 167 (2001) 188-195
32. Miller A., Lider O., Roberts A.B., Sporn M.B., and Weiner H.L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A 89 (1992) 421-425
33. Mowat A.M., Lamont A.G., Strobel S., and MacKenzie S. The role of antigen processing and suppressor T cells in immune responses to dietary proteins in mice. Adv Exp Med Biol 216A (1987) 709-720
34. Roncarolo M.G., and Levings M.K. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 12 (2000) 676-683
35. Sakaguchi S. Regulatory T cells. key controllers of immunologic self-tolerance. Cell 101 (2000) 455-458
36. Ludviksson B.R., Seegers D., Resnick A.S., and Strober W. The effect of TGF-beta1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells. Eur J Immunol 30 (2000) 2101-2111
37. Strober W., Kelsall B., and Marth T. Oral tolerance. J Clin Immunol 18 (1998) 1-30
38. Hahn B.H., Singh R.P., La Cava A., and Ebling F.M. Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors. J Immunol 175 (2005) 7728-7737
39. Scotto L., Naiyer A.J., Galluzzo S., Rossi P., Manavalan J.S., Kim-Schulze S., Fang J., Favera R.D., Cortesini R., and Suciu-Foca N. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells. Hum Immunol 65 (2004) 1297-1306
40. Heath W.R., and Carbone F.R. Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 1 (2001) 126-134
41. Heath W.R., and Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19 (2001) 47-64
42. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711
43. Huang F.P., Platt N., Wykes M., Major J.R., Powell T.J., Jenkins C.D., and MacPherson G.G. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 191 (2000) 435-444
44. van de W.Y., Corazza N., Allez M., Mayer L.F., Iijima H., Ryan M., Cornwall S., Kaiserlian D., Hershberg R., Koezuka Y., Colgan S.P., and Blumberg R.S. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology 124 (2003) 1420-1431
45. Allez M., Brimnes J., Dotan I., and Mayer L. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 123 (2002) 1516-1526
46. Grdic D., Hornquist E., Kjerrulf M., and Lycke N.Y. Lack of local suppression in orally tolerant CD8-deficient mice reveals a critical regulatory role of CD8+ T cells in the normal gut mucosa. J Immunol 160 (1998) 754-762
47. Cornet A., Savidge T.C., Cabarrocas J., Deng W.L., Colombel J.F., Lassmann H., Desreumaux P., and Liblau R.S. Enterocolitis induced by autoimmune targeting of enteric glial cells. a possible mechanism in Crohn's disease?. Proc Natl Acad Sci USA 98 (2001) 13306-13311
48. Wedel T., Krammer H.J., Kuhnel W., and Sigge W. Alterations of the enteric nervous system in neonatal necrotizing enterocolitis revealed by whole-mount immunohistochemistry. Pediatr Pathol Lab Med 18 (1998) 57-70
49. Read S., Malmstrom V., and Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192 (2000) 295-302
50. Kursar M., Bonhagen K., Fensterle J., Kohler A., Hurwitz R., Kamradt T., Kaufmann S.H., and Mittrucker H.W. Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J Exp Med 196 (2002) 1585-1592
51. Piccirillo C.A., and Shevach E.M. Cutting edge. control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 167 (2001) 1137-1140